Lanean...
Clinical use of the β(3) adrenoceptor agonist mirabegron in patients with overactive bladder syndrome
Mirabegron is a β(3) adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β(3) adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding other targets in the bladder, and it may also r...
Gorde:
| Argitaratua izan da: | Ther Adv Urol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549701/ https://ncbi.nlm.nih.gov/pubmed/26425139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215591763 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|